Cilcare Names New Chief Medical Officer
Cilcare appointed Bettina Cockroft as its new CMO who will leverage years of expertise in clinical development and biopharma innovation.
Cilcare appointed Bettina Cockroft as its new CMO who will leverage years of expertise in clinical development and biopharma innovation.
CILcare, a CRO specializing in ear disorders, announced the appointment of Aurore Marie at the position of Global Head, R&D Operations Management. In her new role, Marie will drive support to production activities at the global level and will serve as a new member of CILcare’s Board, according to the company.
Vertidiag is said to have developed a technical platform to induce controlled vestibular disorders and to measure their functional impacts. This platform uses behavioral pharmacology, along with a battery of cellular and molecular biology tools that support the understanding of the mechanisms of action of potential drug candidates.